{
    "id": "47195416",
    "text": "THJ-018 is a synthetic cannabinoid that is the indazole analogue of JWH-018 and has been sold online as a designer drug. ==Pharmacology== THJ-018 acts as a full agonist with a binding affinity of 5.84 nM at CB1 and 4.57 nM at CB2 cannabinoid receptors. ==Legality== THJ-018 is an Anlage II controlled drug in Germany. It is also banned in Sweden. == See also == * THJ-2201 * AM-2201 == References == Category:Cannabinoids Category:Designer drugs Category:Naphthoylindazoles ",
    "title": "THJ-018"
}